Since liver TRM normally develop without TGF-β (and therefore lack CD103 expression), the presence of CD103+ TRMs suggests that the cell fate of this population could have been determined by the original tumor microenvironment [24]. The gene discussed is TGFB1; the disease is neoplasm.